Dialysis Market Overview
Dialysis is a process that involves clinical purification of blood, by removing waste such as urea, creatinine, and excess water from blood and is majorly used as an artificial replacement of kidney function in the patients. Dialysis also find its application in patients suffering from chronic renal failure, renal diseases, and kidney transplant. According to the Centers for Disease Control and Prevention (CDC), around 4.9 million adults were diagnosed with the kidney diseases, in the U.S., in 2015. Therefore, the rising prevalence of chronic renal disease has been fueling the demand of dialysis products and services, leading the overall growth of global dialysis market.
The dialysis market is broadly classified into two major systems, namely hemodialysis and peritoneal dialysis. Hemodialysis is further categorized as conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis, and peritoneal dialysis is bifurcated as continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). The adoption of hemodialysis is more as compared to peritoneal dialysis due to the less awareness about peritoneal dialysis. Among the end users, in 2016 in-center dialysis held the largest share of the market in comparison to home dialysis. The preference of in-center over home dialysis is attributed to the fact that in-center dialysis is performed in hospitals and independent centers under clinical supervision.
The products offering of hemodialysis market includes machines and consumables, among which dialyzers, access products, blood lines, and concentrates are the different available consumables in the global market. Some of the peritoneal dialysis products available in the market includes concentrates/dialysates, machines, catheters, and transfer sets.
Dialysis Market Dynamics
Global dialysis market is expected to grow considerably during the forecast period, due to an increase in number of end stage renal disease (ESRD) patients, rise in incidences of diabetes and hypertension, and increase in funding for development of new products.
According to the U.S. renal data system annual data report, more than 660,000 U.S. citizen were treated for kidney failure, also known as ESRD in 2016. Among these more than 193,000 had a functioning kidney transplant and 468,000 are dialysis patients.
As per the reports of World Health Organization (WHO) on diabetes, number of people suffering from diabetes has increased from 108 million in 1980 to 422 million in 2014. Also, the prevalence of diabetes globally has risen from 4.7% in 1980 to 8.5% in 2014.
Additionally, government and private players have increased funding on the development of improved dialysis process. Thus, adequate investment for the innovation of dialysis products to treat the prevailing disease are driving the growth of the market.
The risk and complications associated with the dialysis, stringent regulatory policies for approval and manufacturing of dialysis products, and unfavourable reimbursement policies act as major barriers in the growth of the dialysis market.
Some of the health risks associated post dialysis includes itchy skins, abdominal pain, bleeding, muscle cramps, electrolyte and fluid imbalance. It may also lead to low blood pressure, sleep problems, anemia, amyloidosis, depression and bone diseases. These health complications act as a restraining factor to the growth of the dialysis market and requires R&D approach for better product range that would aid in reducing the side effects linked to the dialysis treatment.
Food and Drug Administration (FDA) has various stringent regulatory guidelines for the safe usage of the dialysis products involved with its quality assurance. JCAHO 10-step process for monitoring and evaluation, and the Smith-Marker "unit-based quality assurance model” are few of the guidelines provided by USFDA for the safe usage of the dialysis products. These complex regulations delay the approval of products and thus, are restraint for the growth of the dialysis market.
Opportunities and Trends
The key trend witnessed in the dialysis market globally, is the rising acceptance of peritoneal dialysis treatment, due to its product portability and convenience of in house usage. The peritoneal dialysis can be done easily at home and sometimes can be done while sleeping. This has led the key players to focus and manufacture product range under the peritoneal dialysis treatment section and also increases the opportunity to develop enhanced products. Thus, patients are increasingly adopting the peritoneal dialysis and it is expected to grow faster as compared to the hemodialysis during forecast period. The untapped markets in the developing economies, and the increasing number of dialysis centers are creating ample opportunities for the growth of the overall dialysis market.
Dialysis Market Insights by Geography
Geographically, North America was the largest market for dialysis in 2016, followed by Europe. The North American dialysis market is primarily driven by the presence of key established players in the market, developed reimbursement policies, and the prevalence of obesity and kidney diseases. The growth of European dialysis market is driven by increasing healthcare expenditure, and rising prevalence of diabetes. Asia-Pacific is expected to grow at the fastest pace during the forecast period, due to the huge patient population base, improving reimbursement and insurance scenario, increasing government healthcare initiatives, and growing number of dialysis centers.
Dialysis Market Competitive Landscape
Some of the key players in the dialysis market across the globe are Fresenius Medical Care AG & Co. KGaA, DaVita Inc., B. Braun Melsungen AG, Nikkiso Co. Ltd., Asahi Kasei Corporation, Medicators, Inc., NxStage Medical, Inc., Diaverum Deutschland GmbH, Nipro Corporation, and Baxter International, Inc.
The key players are readily tapping the untapped market with more innovative products and increasing their market presence which is leading to the growth of the dialysis market.
In May 2017, NxStage Medical, Inc. received clearance from FDA for the next generation hemodialysis system. It consists of new features and capabilities, including a touchscreen user interface and integrated blood pressure monitor designed to enhance ease of use for patients performing home hemodialysis.